Starpharma announced it has signed a new DEP® Research Agreement with MSD (tradename of Merck & Co., Inc., Rahway, N.J., USA). Under the new agreement, Starpharma will design and synthesize a number of DEP® dendrimer conjugates and will provide them to MSD for testing and characterisation.